Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 21.49
-0.24 (-1.10%)
Sep 18, 2026, 3:04 PM CST
SHE:002262 Market Cap
SHE:002262 has a market cap or net worth of 21.83 billion as of September 18, 2026. Its market cap has decreased by -23.30% in one year.
Market Cap
21.83B
Enterprise Value
18.13B
Revenue
6.12B
Ranking
n/a
PE Ratio
19.71
Stock Price
21.49
ChartMarket Cap Chart
Since July 23, 2008, SHE:002262's market cap has increased from 1.26B to 21.83B, an increase of 1,626.32%. That is a compound annual growth rate of 16.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 21.83B | -10.94% |
| Dec 31, 2025 | 24.51B | -0.94% |
| Dec 31, 2024 | 24.74B | -9.45% |
| Dec 29, 2023 | 27.33B | 10.47% |
| Dec 30, 2022 | 24.74B | 56.87% |
| Dec 31, 2021 | 15.77B | -2.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Huahai Pharmaceutical | 24.05B |
| Hubei Jumpcan Pharmaceutical | 23.22B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.02B |
| Walvax Biotechnology | 21.29B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Hybio Pharmaceutical | 20.76B |
| Tasly Pharmaceutical Group | 20.71B |
| Livzon Pharmaceutical Group | 20.65B |